drugset / Trial / NCT03662282
Omegaven as Alternative Parenteral Fat Nutrition
NaSingle-groupOpen-labelTreatment
Summary
To provide Omegaven® as a compassionate treatment for critically ill infants with parenteral nutrition associated cholestasis
Timeline
- Start
- 2018-10-23
- Primary completion
- 2019-01-07
- Completion
- 2019-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omegaven | Other / unclassified | 0.5 unknown | Intravenous |
| Subject | Omegaven | Other / unclassified | 1 unknown | Intravenous |